ORLANDO, FL , a client company of the award-winning University
of Central Florida Technology Incubator program, announced today
that BUYINS.NET, www.buyins.net, is initiating coverage of
Cardiovascular Sciences after releasing the latest short sale data
to April 2008. From October 2007 to April 2008 approximately 18
million total aggregate shares of CVSC have traded for a total
dollar value of nearly $33 million. The total aggregate number of
shares shorted in this time period is approximately 2.3 million
shares. The CVSC SqueezeTrigger price of $1.80 is the volume
weighted average short price of all short selling in CVSC. A short
squeeze began when shares of CVSC closed above $1.80, which is the
cumulative SqueezeTrigger price of all short selling in CVSC. To
access SqueezeTrigger Prices ahead of potential short squeezes
beginning, visit http://www.buyins.net.
Month Total Vol. Short Vol. Avg. Price Short $ Value
----- ---------- ---------- ---------- -------------
October '07 19,478 2,532 $0.24 $614
November 65,730 8,545 $0.37 $3,183
December 152,182 19,784 $0.45 $8,853
January '08 101,853 13,241 $0.95 $12,513
February 1,954,312 254,061 $1.19 $301,697
March 14,063,558 1,828,263 $1.90 $3,469,128
April 1,742,396 226,511 $2.01 $455,287
Total: 18,099,509 2,352,937 $1.80 $4,251,275
*short volume is approximated using a proprietary algorithm.
**average short price is calculated using a volume weighted average short
price.
***short volume is the total short trade volume and does not account for
covers.
About Cardiovascular Sciences, Inc.
Cardiovascular Sciences, Inc. is an advanced medical device
company which is developing a novel technology platform to address
the problem of post-surgical and post-traumatic adhesions.
Adhesions and the complications of adhesions are a significant
problem worldwide for a wide range of specialists, including
general surgeons, cardiothoracic surgeons, orthopedic, plastic, and
ophthalmologic and otolaryngology specialists to name just some of
them. In addition, the veterinary field has a tremendous need for a
product that can prevent similar problems in a wide variety of
animals. The Company's unique materials and processes promise a
more cost-effective and decidedly more efficient and capable means
to deal with a problem that has been so devastating to so many.
Current sponsored research at the University of Central Florida
(UCF) and previously at other institutions indicate that The
Company is on the right path and progressing well. In addition to
the anti-adhesion technology, The Company owns technology in a
variety of other areas, including thrombo-resistant coatings,
enhanced intra-arterial balloon pumping catheters, cell engineered
vascular tissues, and a method for improved recovery of the heart
following cardioplegia. This yields a diversified portfolio with
projects in various stages of development. www.cvsciences.org.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide
shareholders of publicly traded US companies fight naked short
selling. Naked short selling is the illegal act of short selling a
stock when no affirmative determination has been made to locate
shares of the stock to hypothecate in connection with the short
sale. Buyins.net has built a proprietary database that uses
Threshold list feeds from NASDAQ, AMEX and NYSE to generate
detailed and useful information to combat the naked short selling
problem. For the first time, actual trade by trade data is
available to the public that shows the attempted size, actual size,
price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in
determining the precise point at which short sellers go
out-of-the-money and start losing on their short and naked short
trades.
BUYINS.NET has built a massive database that collects, analyzes
and publishes a proprietary SqueezeTrigger for each stock that has
been shorted. The SqueezeTrigger database of nearly 1,900,000,000
short sale transactions goes back to January 1, 2005 and calculates
the exact price at which the Total Short Interest is short in each
stock. This data was never before available prior to January 1,
2005 because the Self Regulatory Organizations (primary exchanges)
guarded it aggressively. After the SEC passed Regulation SHO,
exchanges were forced to allow data processors like Buyins.net to
access the data.
The SqueezeTrigger database collects individual short trade data
on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade
data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the
database grows by approximately 50,000,000 short sale transactions
and provides investors with the knowledge necessary to time when to
buy and sell stocks with outstanding short positions. By tracking
the size and price of each month's short transactions, BUYINS.NET
provides institutions, traders, analysts, journalists and
individual investors the exact price point where short sellers
start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon
information believed to be reliable. The information contained
herein is not guaranteed by BUYINS.NET to be accurate, and should
not be considered to be all-inclusive. The companies that are
discussed in this opinion have not approved the statements made in
this opinion. Cardiovascular Sciences, Inc. has paid $995 per month
to purchase data for information provided in twelve monthly
reports. The data service can be cancelled at any time. This
opinion contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to
buy or sell securities. BUYINS.NET is not a licensed broker, broker
dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing
or selling any securities viewed on or mentioned herein. BUYINS.NET
will not advise as to when it decides to sell and does not and will
not offer any opinion as to when others should sell; each investor
must make that decision based on his or her judgment of the
market.
BUYINS.NET and SQUEEZETRIGGER are intended for use by stock
market professionals. As a member, visitor, or user of any kind,
you accept full responsibilities for your investment and trading
actions. The contents of BUYINS.NET, including but not limited to
all implied or expressed views, opinions, teachings, data, graphs,
opinions, or otherwise are not predictions, warranty, or
endorsements of any kind. Please seek stock market advice from the
proper securities professional, or investment advisor.
By visiting BUYINS.NET or using any data or services, you agree
to assume full responsibility for the decisions or actions that you
undertake. BUYINS.NET, LLC, its owner(s), operators, employees,
partners, affiliates, advertisers, information providers and any
other associated person or entity, shall under no circumstances be
held liable to the user and/or any third party for loss or damages
of any kind, including but not limited to trading losses, lost
trading opportunity, direct, indirect, consequential, special,
incidental, or punitive damages. As a user, you agree that any
damages collected shall not exceed the amount paid to BUYINS.NET
and/or its owners. As a website user, you agree that any and all
legal matters of any kind are to be reviewed and handled in their
entirety within the State of California only. By using the services
of this website, you are consenting to the terms as outlined, and
forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and
all examples are hypothetical and should not be considered a
guarantee or endorsement of such trading activity. BUYINS.NET does
not take responsibility for problems of any kind, including but not
limited to issues with operations, data accuracy or completeness,
contacting issues, technical issues, and timeliness. BUYINS.NET
places great integrity on the data collected and distributed. This
information is deemed reliable, but not guaranteed. All information
and data is provided "as is" without warranty or guarantee of any
kind.
Please seek investment and/or trading advice, counsel,
information or services from a securities professional. You should
consider these factors in evaluating the forward-looking statements
included herein, and not place undue reliance on such statements.
The forward-looking statements in this release are made as of the
date hereof and BUYINS.NET undertakes no obligation to update such
statements.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the SEC.
Contact: For more information contact: Cardiovascular Sciences
Investor Relations 800-858-7502 ir@cvsciences.org
Cardiovascular Sciences (CE) (USOTC:CVSC)
過去 株価チャート
から 10 2024 まで 12 2024
Cardiovascular Sciences (CE) (USOTC:CVSC)
過去 株価チャート
から 12 2023 まで 12 2024
